홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Pramipexole hydrochloride

HCID 9964861
새 반응
인쇄
기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
104632-25-9
표준 SMILES
CCCN[C@H]1CCc2nc(N)sc2C1.Cl
InChIKey
YLOYRMPMRZXEMW-FJXQXJEOSA-N
분자식
C10H18ClN3S
평균 분자량
247.79 g/mol
단동위원소 질량
247.0909965

이름 및 식별자

우선 이름
Pramipexole hydrochloride
IUPAC
(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;hydrochloride
영어명
Pramipexole Impurity 4
분자식
C10H19Cl2N3S
분자량
284.25

이름 및 동의어

PRAMIPEXOLE HClPRAMIPEXOLE HYDROCHLORIDEpramipexole-hclMLS001401423SCHEMBL408536CHEMBL542257YLOYRMPMRZXEMW-FJXQXJEOSA-NPharmakon1600-01504202(R)-Pramipexole (dihydrochloride);R-(+)-Pramipexole (dihydrochloride);KNS-760704 (dihydrochloride)NSC760426AKOS025311446CCG-100929
이름 더 보기
PRAMIPEXOLE DIHYDROCHLORIDECS-296PraxolePRAMPEXOL HCLPRAMIPEXOL HCLPramipexoleDihclPramepexole 2HClCrufomate Impurity 4
GS-3187NC00179SMR000469142(6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine hydrochloride

데이터베이스 식별자

CAS
104632-25-9、104632-26-0
PubChem CID
9964861
ChEMBL
CHEMBL542257

물성

구조 계산 물성

극성 표면적
79.2 Ų
수소 결합 공여자 수
3
수소 결합 수용자 수
4
회전 가능 결합 수
3
무거운 원자 수
15
형식 전하
0
복잡도
188

물리화학적 성질

녹는점
288 · 288-290°C
저장 조건
2 · 2-8°C
용해도
2 O: · H2O: >20mg/mL
물리적 상태
가루
색상
흰색에서 황백색까지
수용성
2 O: · H2O: >20mg/mL
InChI
1S/C10H17N3S.2ClH/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8;;/h7,12H,2-6H2,1H3,(H2,11,13);2*1H/t7-;;/m0../s1
InChIKey
QMNWXHSYPXQFSK-KLXURFKVSA-N
SMILES
Cl.Cl.CCCN[C@H]1CCc2nc(N)sc2C1

화학적 성질

White Crystalline Powder

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

안전 데이터

wgk
3
Hazard Classifications
Acute Tox. 4 OralSTOT SE 3
스토리지 클래스
11 - Combustible Solids

화학 및 산업

응용 분야 · 2건

개요Mirapex, an non ergot derivative, was launched in the US for treatment of Parkinson's disease. It can be prepared by two related routes, 5 steps and 3 steps, both involving an optical resolution with L-(+)-tartaric acid to afford the (S)-isomer. Mechanistically, it is a presynaptic dopamine D2 autoreceptor agonist which also activates D3-receptors. It is well absorbed from the GI and excreted in the urine essentially unchanged with a half-life of 8-12 hr. Mirapex had favorable effects on the symptoms without levodopa for patients with advanced PD and allowed a 27% reduction in use of levodopa in combination therapy. It had an adverse events profile similar to other dopamine agonists and in advanced patients reduced the mean "on-off" hr/day from 6 to 4. It was safe but not efficacious in all patients.

일반 설명Pramipexole dihydrochloride,(S)-2-amino-6-propylamino-dihydrochloride(Mirapex), is a white to off-white powder soluble in water,slightly soluble in methanol and ethanol, and practically insolublein dichloromethane. Following oral administration,pramipexole is readily absorbed. Pharmacokinetic propertiesdiffer between men and women, with area under the curve(AUC) for each dose level being 35% to 43% greater inwomen, mainly because of a 24% to 27% lower oral clearance.The drug undergoes minimal hepatic biotransformationand is excreted virtually unchanged in the urine by the renaltubular secretion. Pramipexole interacts with drugs excretedby renal tubular secretion (H2-antagonists, diuretics, verapamil,quinidine, quinine), which leads to a decreased clearanceof pramipexole.44,45 Pramipexole is indicated fortreatment of the signs and symptoms of idiopathic PD, aloneor in combination with levodopa. It is also indicated for symptomatictreatment of moderate to severe idiopathic restlesslegs syndrome (RLS).

상·하류 제품 정보

상류 원료

티오요소아세트산(빙초산)염산무수프탈산브롬화수소

관련 반응

1건
반응 기록 만들기
HRID 1895895 반응식
HRID 1895895생성물로

화합물 노트

이 페이지에서기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
4-아미노사이클로헥산올염산염
중크롬산 칼륨
나트륨 붕소수화물
하이드라진, 모노수화물
N,N-다이아이소프로필에틸아민
프로피온알데히드

하류 제품

Pramipexole

추가 설명

정의ChEBI: A hydrochloride that is the anhydrous dihydrochloride salt of pramipexole.